Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA

Author： Lentz S.R.   Rodionov R.N.   Dayal S.  

Publisher： Elsevier

ISSN： 1567-5688

Source： Atherosclerosis, Supplements, Vol.4, Iss.4, 2003-12, pp. : 61-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease

By  

Current Cardiology Reviews, Vol. 6, Iss. 2, 2010-05 ,pp. : 82-90

Bentham Science Publishers

Access to resources Recommend Favorite

On the Role of Endothelial TRPC3 Channels in Endothelial Dysfunction and Cardiovascular Disease

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 10, Iss. 3, 2012-09 ,pp. : 265-274

Bentham Science Publishers

Access to resources Recommend Favorite

Homocysteine and ADMA—emerging risk factors for cardiovascular disease?

By Hedner Thomas   Himmelmann Anders   Hansson Lennart  

Blood Pressure, Vol. 11, Iss. 4, 2002-07 ,pp. : 197-200

Informa Healthcare

Access to resources Recommend Favorite

Hyperuricemia: Is it a Risk Factor for Vascular Endothelial Dysfunction and Associated Cardiovascular Disorders?

By  

Current Hypertension Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 1-6

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac Adiposity and Cardiovascular Risk: Potential Role of Epicardial Adipose Tissue

By  

Current Cardiology Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 11-14

Bentham Science Publishers

Access to resources Recommend Favorite